{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:46:17Z","timestamp":1789076777630,"version":"build-2803163510"},"reference-count":19,"publisher":"Hindawi Limited","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Andrologia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/and.12550","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T09:54:33Z","timestamp":1455789273000},"page":"1130-1137","source":"Crossref","is-referenced-by-count":56,"title":["Meningiomas in three male-to-female transgender subjects using oestrogens\/progestogens and review of the literature"],"prefix":"10.1155","volume":"48","author":[{"given":"P. V.","family":"ter Wengel","sequence":"first","affiliation":[{"name":"Neurosurgical Center Amsterdam; VU University Medical Center; Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Martin","sequence":"additional","affiliation":[{"name":"Neurosurgical Center Amsterdam; VU University Medical Center; Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gooren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology; Center of Expertise on Gender Dysphoria; VU University Medical Center; Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Den Heijer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology; Center of Expertise on Gender Dysphoria; VU University Medical Center; Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Peerdeman","sequence":"additional","affiliation":[{"name":"Neurosurgical Center Amsterdam; VU University Medical Center; Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"key":"10.1111\/and.12550-BIB0001|and12550-cit-0001","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/ijc.25184","article-title":"Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study","volume":"127","author":"Benson","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1111\/and.12550-BIB0002|and12550-cit-0002","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.endonu.2012.07.004","article-title":"Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual","volume":"60","author":"Bergoglio","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1111\/and.12550-BIB0003|and12550-cit-0003","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canep.2011.08.003","article-title":"Hormonal therapies and meningioma: is there a link?","volume":"36","author":"Cea-Soriano","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1111\/and.12550-BIB0004|and12550-cit-0004","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00701-010-0787-2","article-title":"Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient","volume":"152","author":"Cebula","year":"2010","journal-title":"Acta Neurochir"},{"key":"10.1111\/and.12550-BIB0005|and12550-cit-0005","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jocn.2010.01.036","article-title":"Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy","volume":"17","author":"Deipolyi","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1111\/and.12550-BIB0006|and12550-cit-0006","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13760-012-0046-9","article-title":"Hormonal therapy for fertility and huge meningioma: a purely random association?","volume":"112","author":"Frassanito","year":"2012","journal-title":"Acta Neurol Belg"},{"key":"10.1111\/and.12550-BIB0007|and12550-cit-0007","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMc071938","article-title":"Growth of a meningioma in a transsexual patient after estrogen-progestin therapy","volume":"357","author":"Gazzeri","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/and.12550-BIB0008|and12550-cit-0008","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","article-title":"Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study","volume":"72","author":"Gil","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/and.12550-BIB0009|and12550-cit-0009","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3174\/ajnr.A1978","article-title":"Abrupt regression of a meningioma after discontinuation of cyproterone treatment","volume":"31","author":"Gon\u00e7alves","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1111\/and.12550-BIB0010|and12550-cit-0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","article-title":"Clinical practice. Care of transsexual persons","volume":"364","author":"Gooren","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1111\/and.12550-BIB0011|and12550-cit-0011","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.maturitas.2003.09.021","article-title":"Differential effects of progestins on the brain","volume":"46","author":"Gruber","year":"2003","journal-title":"Maturitas"},{"key":"10.1111\/and.12550-BIB0012|and12550-cit-0012","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/15532739.2012.725563","article-title":"Recurrence and progression of meningioma in Male-to-Female transgender individuals during exogenous hormone use","volume":"14","author":"Knight","year":"2013","journal-title":"Int J Transgend"},{"key":"10.1111\/and.12550-BIB0013|and12550-cit-0013","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/aje\/kwr335","article-title":"A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland","volume":"175","author":"Korhonen","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1111\/and.12550-BIB0014|and12550-cit-0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-08-0289","article-title":"Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones","volume":"159","author":"Mueller","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/and.12550-BIB0015|and12550-cit-0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1227\/00006123-199404000-00022","article-title":"Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant","volume":"34","author":"Piper","year":"1994","journal-title":"Neurosurgery"},{"key":"10.1111\/and.12550-BIB0016|and12550-cit-0016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2176\/nmc.48.227","article-title":"Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration","volume":"48","author":"Shimizu","year":"2008","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1111\/and.12550-BIB0017|and12550-cit-0017","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<714::AID-IJC2>3.0.CO;2-V","article-title":"Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in\u00a0vitro cell cultures to steroid hormones","volume":"72","author":"Speirs","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1111\/and.12550-BIB0018|and12550-cit-0018","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3171\/2009.8.JNS09201","article-title":"Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy","volume":"112","author":"Vadivelu","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1111\/and.12550-BIB0019|and12550-cit-0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"}],"container-title":["Andrologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fand.12550","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fand.12550","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/and.12550\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:36:48Z","timestamp":1671539808000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/and.12550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/and.12550","archive":["Portico"],"relation":{},"ISSN":["0303-4569"],"issn-type":[{"value":"0303-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2,16]]}}}